The purpose of this study is to determine the effectiveness of three repurposed medications in slowing the progression of Parkinson’s Disease (PD) and maintaining a positive effect for a period after the medication has been stopped.
This study is being conducted across Australia. A total of 240 participants will be enrolled over 8 sites. Participant involvement in the trial will last 62 weeks which will include 6 visits to the study clinic.
Please see the Australian Parkinson’s Mission website for more details.
You may be eligible to participate in this study if you:
If you are interested in assisting with this important and exciting area of research, please contact the study facilitator on 9114 4172 or email email@example.com